Rep. Marjorie Taylor Greene Purchases Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Representative Marjorie Taylor Greene acquired shares of UnitedHealth Group (NYSE:UNH), investing between $1,001 and $15,000 on August 4th, as disclosed in a recent filing.
• UnitedHealth Group reported earnings of $4.08 per share for the last quarter, falling short of the consensus estimate of $4.45, with a year-over-year revenue increase of 12.9%.
• The company announced a quarterly dividend of $2.21 per share, which will be paid to stockholders of record on September 15th, representing a yield of 2.9%.

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 15th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on August 4th.

Representative Marjorie Taylor Greene also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of AbbVie NYSE: ABBV on 8/4/2025.
• Purchased $1,001 - $15,000 in shares of United Parcel Service NYSE: UPS on 8/4/2025.
• Purchased $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 7/15/2025.
• Purchased $1,001 - $15,000 in shares of Palantir Technologies NASDAQ: PLTR on 7/15/2025.
• Purchased $1,001 - $15,000 in shares of Tractor Supply NASDAQ: TSCO on 6/17/2025.
• Purchased $1,001 - $15,000 in shares of Snowflake NYSE: SNOW on 6/17/2025.
• Sold $1,001 - $15,000 in shares of lululemon athletica NASDAQ: LULU on 6/17/2025.
• Purchased $1,001 - $15,000 in shares of Netflix NASDAQ: NFLX on 6/6/2025.
• Purchased $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 6/6/2025.
• Purchased $1,001 - $15,000 in shares of Gilead Sciences NASDAQ: GILD on 6/6/2025.

UnitedHealth Group Stock Up 12.0%

UnitedHealth Group stock traded up $32.53 during midday trading on Friday, reaching $304.02. The company's stock had a trading volume of 67,934,484 shares, compared to its average volume of 21,947,932. The stock's 50-day simple moving average is $288.91 and its 200-day simple moving average is $395.81. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The stock has a market capitalization of $275.34 billion, a P/E ratio of 13.17, a PEG ratio of 1.96 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter last year, the business posted $6.80 earnings per share. The company's quarterly revenue was up 12.9% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.28% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. Bank of America reduced their price objective on UnitedHealth Group from $350.00 to $300.00 and set a "neutral" rating for the company in a research note on Tuesday, July 29th. JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday, August 6th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Argus cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Finally, Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $366.52.

Institutional Trading of UnitedHealth Group

Institutional investors have recently made changes to their positions in the company. Brighton Jones LLC boosted its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG raised its holdings in shares of UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock valued at $133,373,000 after buying an additional 9,872 shares during the period. Jump Financial LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $1,321,000. Finally, MSH Capital Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $476,000. 87.86% of the stock is owned by institutional investors and hedge funds.

About Representative Greene

Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia's 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027. Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia's 14th Congressional District. She declared candidacy for the 2026 election.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.